Collection 5 (Sep 2024 - Aug 2025) Articles

Articles
Influence of Subclinical Atherosclerosis Burden and Progression on Mortality
Fuster V, García-Álvarez A, Devesa A, et al.
Journal:
J Am Coll Cardiol

First published: October 8, 2024 DOI: 10.1016/j.jacc.2024.06.045
View
- Share
Articles
Within-person stability of lipoprotein(a) concentration
Ghouse J, Ahlberg G, Albertsen Rand S, et al.
Journal:
Eur Heart J

First published: October 8, 2024 DOI: 10.1093/eurheartj/ehae652
View
- Share
Articles
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC)
Journal:
Lancet Diabetes Endocrinol

First published: October 3, 2024 DOI: 10.1016/S2213-8587(24)00221-3
View
- Share
Articles
Efficacy and safety of statins, ezetimibe and statins-ezetimibe therapies for children and adolescents with heterozygous familial hypercholesterolaemia: Systematic review, pairwise and network meta-analyses of randomised controlled trials
Llewellyn A, Simmonds M, Marshall D, et al.
Journal:
Atherosclerosis

First published: September 28, 2024 DOI: 10.1016/j.atherosclerosis.2024.118598
View
- Share
Articles
Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome
Zahger D, Schwartz GG, Du W, et al.
Journal:
J Am Coll Cardiol

First published: September 10, 2024 DOI: 10.1016/j.jacc.2024.06.035
View
- Share
Articles
Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial
Gibson CM, Duffy D, Bahit MC, et al.
Journal:
Eur Heart J

First published: September 2, 2024 DOI: 10.1093/eurheartj/ehae614
View
- Share
Articles
Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry
Schubert J, Leosdottir M, Lindahl B, et al.
Journal:
Eur Heart J

First published: September 1, 2024 DOI: 0.1093/eurheartj/ehae576
View
- Share
Articles
Non-HDL-cholesterol reduction: the challenges of applying clinical trial results in the real world
De Geest B, Van Linthout S
Journal:
Eur Heart J

First published: September 1, 2024 DOI: 10.1093/eurheartj/ehae577
View
- Share

1 2 3

Collection 5 (Sep 2024 - Aug 2025) Articles

Articles

Influence of Subclinical Atherosclerosis Burden and Progression on Mortality

Fuster V, García-Álvarez A, Devesa A, et al.

Articles

Within-person stability of lipoprotein(a) concentration

Ghouse J, Ahlberg G, Albertsen Rand S, et al.

Articles

Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC)

Articles

Efficacy and safety of statins, ezetimibe and statins-ezetimibe therapies for children and adolescents with heterozygous familial hypercholesterolaemia: Systematic review, pairwise and network meta-analyses of randomised controlled trials

Llewellyn A, Simmonds M, Marshall D, et al.

Articles

Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome

Zahger D, Schwartz GG, Du W, et al.

Articles

Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial

Gibson CM, Duffy D, Bahit MC, et al.

Articles

Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry

Schubert J, Leosdottir M, Lindahl B, et al.

Articles

Non-HDL-cholesterol reduction: the challenges of applying clinical trial results in the real world

De Geest B, Van Linthout S

Articles

Influence of Subclinical Atherosclerosis Burden and Progression on Mortality

Fuster V, García-Álvarez A, Devesa A, et al.

Share

Articles

Within-person stability of lipoprotein(a) concentration

Ghouse J, Ahlberg G, Albertsen Rand S, et al.

Share

Articles

Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC)

Share

Articles

Efficacy and safety of statins, ezetimibe and statins-ezetimibe therapies for children and adolescents with heterozygous familial hypercholesterolaemia: Systematic review, pairwise and network meta-analyses of randomised controlled trials

Llewellyn A, Simmonds M, Marshall D, et al.

Share

Articles

Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome

Zahger D, Schwartz GG, Du W, et al.

Share

Articles

Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial

Gibson CM, Duffy D, Bahit MC, et al.

Share

Articles

Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry

Schubert J, Leosdottir M, Lindahl B, et al.

Share

Articles

Non-HDL-cholesterol reduction: the challenges of applying clinical trial results in the real world

De Geest B, Van Linthout S

Share